🔎 Trials Near Me

Home › Chronic Myelomonocytic Leukemia › Ohio › Columbus

Pag-aaral pangklinika para sa Chronic Myelomonocytic Leukemia sa Columbus, OH

4 pag-aaral para sa Chronic Myelomonocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Columbus (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

Nagre-recruitPhase 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07249346

Axatilimab With or Without Azacitidine for the Treatment of Patients With Advanced Phase Myeloproliferative Neoplasms, Myeloproliferative Neoplasm/Myelodysplastic Syndrome Overlap or High Risk Chronic Myelomonocytic Leukemia

Nagre-recruitPhase 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT06523556

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

Nagre-recruitPhase 2/3
  • Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Abr 30, 2026 · NCT04256317

Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1/2
  • The Ohio State University Wexner Medical Center, Columbus
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 26, 2025 · NCT03850574

Pag-aaral para sa Chronic Myelomonocytic Leukemia sa ibang lungsod

Iba pang pag-aaral sa Columbus

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.